Sartorius AG

General ticker "SUVPF" information:

  • Sector: Health Care
  • Industry: Medical - Instruments & Supplies
  • Capitalization: $18.0B (TTM average)

Sartorius AG follows the US Stock Market performance with the rate: 18.3%.

Estimated limits based on current volatility of 0.1%: low 256.35$, high 256.88$

Factors to consider:

  • Company pays dividends (annually): last record date 2026-03-30, amount 0.85$ (Y0.33%)
  • Earnings for 18 months up through Q2 (+1 year) exceed our estimates

Stock Forecast*

* forecast is subjective and experimental, should not be used for any investment decisions

Long term estimates were made for the period from 2024-12-31 to 2026-12-31

  • 2024-12-31 to 2025-12-31 estimated range: [154.02$, 284.34$]
  • 2025-12-31 to 2026-12-31 estimated range: [148.66$, 275.58$]

Financial Metrics affecting the SUVPF estimates:

  • Negative: with PPE of 125.4 at the end of fiscal year the price was high
  • Positive: 7.78 < Operating profit margin, % of 12.93
  • Positive: Interest expense per share per price, % of 1.46 <= 3.33
  • Positive: -9.07 < Industry operating profit margin (median), % of -7.92
  • Negative: Industry earnings per price (median), % of 0 <= 0
  • Positive: Inventory ratio change, % of -9.93 <= -0.76
  • Positive: 0.30 < Operating cash flow per share per price, % of 6.73
  • Positive: -3.09 < Return on assets ratio (scaled to [-100,100]) of 0.82
  • Positive: 19.10 < Shareholder equity ratio, % of 27.37 <= 42.34

Similar symbols

Short-term SUVPF quotes

Long-term SUVPF plot with estimates

Financial data

YTD 2023-12-31 2024-12-31 2025-12-31
Operating Revenue €3,395.70MM €3,380.70MM €3,536.77MM
Operating Expenses €2,852.50MM €2,943.50MM €2,885.62MM
Operating Income €543.20MM €437.20MM €651.16MM
Non-Operating Income €-157.30MM €-250.40MM €-314.28MM
Interest Expense €144.90MM €212.63MM €197.93MM
R&D Expense €170.80MM €196.80MM €173.93MM
Income(Loss) €385.90MM €186.80MM €336.87MM
Taxes €95.90MM €49.40MM €106.56MM
Net Income(Loss)* €205.20MM €84.00MM €154.84MM
Stockholders Equity €2,067.30MM €2,764.80MM €2,705.79MM
Inventory €1,036.70MM €788.50MM €791.90MM
Assets €9,755.30MM €10,103.00MM €9,713.56MM
Operating Cash Flow €853.60MM €976.20MM €655.75MM
Capital expenditure €559.70MM €409.90MM €441.73MM
Investing Cash Flow €-2,823.30MM €-425.80MM €-513.31MM
Financing Cash Flow €2,165.70MM €-128.30MM €-410.45MM
Earnings Per Share** €3.00 €1.22 €2.24

* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.